X-ray CT guided fault-free photothermal ablation of metastatic lymph nodes with ultrafine HER-2 targeting W18O49 nanoparticles

Biomaterials

Volumn 35, Issue 33, 2014, Pages 9155-9166

  Huo, Da ^a   He, Jian ^a   Li, Hui ^a   Huang, Ai J ^a   Zhao, Hui Y ^a   Ding, Yin ^a   Zhou, Zheng Y ^a   Hu, Yong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Computed tomography; HER 2; Metastasis; Nanoparticles; Photothermal therapy; Tungsten oxide

Indexed keywords

ABLATION; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; ENZYME INHIBITION; MEDICAL IMAGING; NANOPARTICLES; PATHOLOGY;

HER-2; LYMPHATIC METASTASIS; METASTASIS; METASTATIC LYMPH NODES; PHOTOTHERMAL ABLATION; PHOTOTHERMAL THERAPY; THERAPEUTIC EFFICACY; TUNGSTEN OXIDE;

SYNTHESIS (CHEMICAL);

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; METAL NANOPARTICLE; TUNGSTEN OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; NANOPARTICLE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BREAST CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIC THERAPY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; ANIMAL; BREAST TUMOR; CHEMISTRY; DRUG SCREENING; FEMALE; GENETICS; LYMPH NODE; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; RABBIT; TUMOR CELL LINE;

MUS;

ABLATION TECHNIQUES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; NANOPARTICLES; RABBITS; RECEPTOR, ERBB-2; TOMOGRAPHY, X-RAY COMPUTED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84906783526     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.034     Document Type: Article

References (29)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 63:69-90.
2. A'Hern R.P., Smith I.E., Ebbs S.R. Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in cooper type regimens. Br J Cancer 1993, 67:801-805.
3. Greenberg P.A., Hortobagyi G.N., Smith T.L., Ziegler L.D., Frye D.K., Buzdar A.U. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. JClin Oncol 1996, 14:2197-2205.
4. McMasters K.M., Tuttle T.M., Carlson D.J., Brown C.M., Noyes R.D., Glaser R.L., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. JClin Oncol 2000, 18:2560-2566.
5. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 1999, 6:109-116.
6. Lucci A., McCall L.M., Beitsch P.D., Whitworth P.W., Reintgen D.S., Blumencranz P.W., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. JClin Oncol 2007, 24:3657-3663.
7. Erickson V.S., Pearson M.L., Ganz P.A., Adams J., Kahn K.L. Arm edema in breast cancer patients. JNatl Cancer Inst 2001, 93:96-111.
8. Ozmen V., Muslumanoglu M., Cabioglu N., Tuzlali S., IIhan R., Igci A., et al. Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat 2002, 76:237-244.
9. Song K.H., Kim C.H., Cobley C.M., Xia Y.N., Wang L.V. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett 2009, 9:183-188.
10. Wilke L.G., McCall L.M., Posther K.E., Whitworth P.W., Reintgen D.S., Leitch A.M., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006, 13:491-500.
11. 49 nanowires. Angew Chem Int Ed 2013, 52:12332-12336.
12. 49 nanowires as a new 980 nm-laser-driven photothermal agent for efficient ablation of cancer cells invivo. Adv Mater 2013, 25:2095-2100.
13. Zhou Z.G., Kong B., Yu C., Shi X.Y., Wang M.W., Liu W., et al. Tungsten oxide nanorods: an efficient nanoplatform for tumor CT imaging and photothermal yherapy. Sci Rep 2014, 4:3653-3660.
14. Liu J.H., Han J.G., Kang Z.C., Golamaully R., Xu N.N., Li H.P., et al. Invivo near-infrared photothermal therapy and computed tomography imaging of cancer cells using novel tungsten-based theranostic probe. Nanoscale 2014, 6:5770-5776.
15. Chauhan V.P., Stylianopoulos T., Maryin J.D., Popovic Z., Chen O., Kamoun W.S., et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 2012, 7:383-388.
16. Kobayashi H., Hama Y., Koyama Y., Barrett T., Regino C.A., Urano Y., et al. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett 2007, 7:1711-1716.
17. Kim K.H., Geronemus R.G. Laser lipolysis using a novel 1,064 nm Nd: YAG laser. Dermatol Surg 2006, 32:241-248.
18. Allred D.C., Clark G.M., Tandon A.K., Molina R., Tormey D.C., Osborne C.K., et al. HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma. JClin Oncol 1992, 1:599-605.
19. Huo D., Ding J., Cui Y.X., Xia L.Y., Li H., He J., et al. X-ray CT and pneumonia inhibition properties of gold-silver nanoparticles for targeting MRSA induced pneumonia. Biomaterials 2014, 35:7032-7041.
20. Zha Z., Wang J., Zhang S., Wang S., Qu E., Zhang Y., et al. Engineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancer. Biomaterials 2014, 35:287-293.
21. Huo D., Gao J., Guo B.L., Ding Y., He J., Yu H.P., et al. Silver nanoshells as tri-mode bactericidal agents integrating long term antibacterial, photohyperthermia and triggered Ag+ release capabilities. RSC Adv 2013, 3:10632-10638.
22. Jin Y.S., Wang J.R., Ke H.T., Wang S.M., Dai Z.F. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials 2014, 34:4794-4802.
23. 49. RSC Adv 2012, 2:5041-5043.
24. Xu C., Tung G.A., Sun S.H. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 2008, 20:4167-4169.
25. Chen R., Wang X., Yao X.K., Zheng X.C., Wang J., Jiang X.Q. Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials 2013, 34:8314-8322.
26. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999, 6:99-104.
27. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995, 81:801-809.
28. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., Jackon S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005, 123:1213-1226.
29. Luo S.L., Tan X., Qi Q.R., Guo Q.Y., Ran X.Z., Zhang L.L., et al. Amultifunctional heptamethine near-infrared dye for cancer theranosis. Biomaterials 2013, 34:2244-2251.